news
Ontario and Quebec against plan to lower Canadian drug prices
The two Canadian provinces have expressed concern over the new draft regulations, claiming that the reforms would delay patient access to medicines.
List view / Grid view
Drug Supply Chain
news
US sanctions on Iran creating critical drug shortage
The Middle Eastern country has a limited supply of vital medication needed for conditions such as cancer due to US trade blocks.
news
Trump drafts plan to import drugs from Canada
In another bid to lower medication prices in the US, Donald Trump has announced a draft plan to import drugs from Canada.
article
Surge in negative verifications of saleable returns could cost pharma industry billions
The pharmaceutical industry is set to face some major changes in the near future, to improve the quality of returned drugs and medications.
news
Pharma companies to pay California $70m for drug delays
Teva Pharmaceuticals, Endo Pharmaceuticals and Teikoku will pay almost $70 million to the US state for delaying drugs to keep prices high.
news
Drone temperature-controlled medicine delivery programme test completed
The successful pilot programme could represent an important step forward in biopharmaceutical supply chain innovation.
news
Altaire issues sterile product voluntary recall
Altaire Pharmaceuticals has announced a recall of 31 products due to a lack of sterility assurance from their manufacturing facility.
article
Top five generic drug makers
The global generic drugs market continues to grow. With increasing demand for more accessible medication, pharmaceutical companies are harnessing the benefits offered by generic drugs. Here are the top five generic drugs makers by revenue.
news
Chinese drug packaging industry set to be worth RMB200 billion
Pharmaceutical packaging in China has increased at a rate of 10 percent in recent years and is predicted to continue high growth.
news
EU releases guidance for medicine shortages
The EU has issued two guidance documents intended to advise the pharmaceutical industry and patients during medicinal shortages.
news
£3 million for no-deal Brexit medication transport
The DHSC has announced their plans for pharmaceutical transportation in the case of a no-deal Brexit.
news
FDA issues three warning letters to API re-packers
Three API re-packers who failed to meet current good manufacturing practice requirements have received warning letters from the FDA.
article
The impact of counterfeit drugs in south and south-east Asia
Substandard and counterfeit drugs can negatively impact the pharmaceutical industry and patients. Here, we investigate counterfeits in south-east Asia and possible solutions.
news
Jet-lag medication approved by MHRA
The MHRA has given marketing authorisation for short-term jet-lag therapy in adults.
news
Government letter advises pharma industry for no-deal Brexit
The government has issued a letter to the pharmaceutical industry, outlining how to prepare for a no-deal Brexit.
